.svg){kind=small}
Nov-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Aliviar's performance in the Colorado market within the Tincture & Sublingual category has shown some consistency in recent months. Despite a drop in sales from August to November, Aliviar maintained its position at rank 7 from September to November. This steadiness in ranking suggests that despite the fluctuations in sales, Aliviar has managed to hold its ground against competitors in the top 10. However, the brand's inability to climb higher in the rankings might indicate a need for strategic adjustments to capture more market share and improve sales figures.
It's important to note that Aliviar did not appear in the top 30 rankings for any other states or categories, which could be seen as a missed opportunity for expansion or diversification. The absence from other rankings highlights a potential area for growth, as focusing on entering new markets or categories could provide Aliviar with additional revenue streams. This limitation to a single state and category could also suggest a niche focus, but it raises questions about the brand's broader market strategy and its ability to scale beyond its current stronghold.
Competitive Landscape
In the Colorado Tincture & Sublingual category, Aliviar has experienced a notable shift in its competitive positioning over the past few months. Starting in August 2024, Aliviar held the 5th rank, but subsequently dropped to the 7th position from September through November. This decline in rank coincides with a decrease in sales, indicating potential challenges in maintaining market share. Meanwhile, Escape Artists has shown strong performance, consistently ranking within the top four and even securing the top spot in September. Similarly, Stratos has demonstrated upward mobility, climbing from 6th to 2nd place by October, before settling at 5th in November. These trends suggest that Aliviar faces stiff competition from these brands, which have managed to capture consumer interest and drive sales more effectively during this period.
Notable Products
In November 2024, Aliviar's top-performing product was the CBD/THC 20:1 Calm Tincture (1400mg CBD, 70mg THC) in the Tincture & Sublingual category, maintaining its first-place ranking for four consecutive months with sales of 322 units. The CBD/THC/CBN 5:1:1 Sleep Tincture (250mg CBD, 50mg THC, 50mg CBN, 10ml) also held steady in second place, though its sales figures decreased from October. The CBD/THC 2:1 Scented Cream (420mg CBD, 210mg THC, 2oz) rose to third place, showing a significant increase in sales compared to previous months. Meanwhile, the CBD/THC 2:1 Unscented Cream (650mg CBD, 325mg THC, 2oz) dropped to fourth place, experiencing a notable decline in sales. The CBD/THC 2:1 Lavender Cream (650mg CBD / 325mg THC, 2oz) entered the rankings in fifth place, indicating a newer addition to the top products list.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
